Other
Critical Illness
5
Pipeline Programs↗
13
Active Trials↗
3
Companies Involved↗
Critical Illness is an early-stage landscape with 5 programs across 3 companies. The most active players are Neurim Pharmaceuticals Ltd., Fresenius, David T Huang. 5 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
29
clinical trials
Completed11 · 38%
Not yet recruiting6 · 21%
Recruiting4 · 14%
Active, not recruiting3 · 10%
Unknown status2 · 7%
Terminated2 · 7%
Other1 · 3%
Clinical Trials
Trial Activity
29 trials
Real-time Evaluation of an Outlier-based Alerting System
Active, not recruiting·—·Preclinical·NCT06996626·7,445 enrolled
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Completed·—·Phase 2·NCT01985685·66 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)